These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31012160)

  • 1. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
    Romero AH; Rodríguez N; Oviedo H; Lopez SE
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, structure-activity relationship and mechanism of action studies of a series of 4-chloro-1-phthalazinyl hydrazones as a potent agent against Leishmania braziliensis.
    Romero AH; Medina R; Alcala A; García-Marchan Y; Núñez-Duran J; Leañez J; Mijoba A; Ciangherotti C; Serrano-Martín X; López SE
    Eur J Med Chem; 2017 Feb; 127():606-620. PubMed ID: 28119201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Olmo F; Sanz AM; Campayo L; Cano C; Yunta MJ
    J Antimicrob Chemother; 2012 Feb; 67(2):387-97. PubMed ID: 22127582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aryl-quinazolin-4(3H)-ones as an inhibitor of leishmania folate pathway: In vitro biological evaluation, mechanism studies and molecular docking.
    Romero AH; Rodríguez N; Oviedo H
    Bioorg Chem; 2019 Mar; 83():145-153. PubMed ID: 30359795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dehydroxy isoquine and isotebuquine as promising antileishmanial agents.
    Romero AH; Rodríguez N; López SE; Oviedo H
    Arch Pharm (Weinheim); 2019 May; 352(5):e1800281. PubMed ID: 30994941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling six potent and highly selective antileishmanial agents via the open source compound collection 'Pathogen Box' against antimony-sensitive and -resistant Leishmania braziliensis.
    Souza Silva JA; Tunes LG; Coimbra RS; Ascher DB; Pires DEV; Monte-Neto RL
    Biomed Pharmacother; 2021 Jan; 133():111049. PubMed ID: 33378956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
    Costa L; Pinheiro RO; Dutra PM; Santos RF; Cunha-Júnior EF; Torres-Santos EC; da Silva AJ; Costa PR; Da-Silva SA
    PLoS One; 2014; 9(10):e109672. PubMed ID: 25340550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights about resveratrol analogs against trypanothione reductase of
    da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
    J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity, structure-activity relationship of series of 2-(trifluoromethyl)benzo[b][1,8]naphthyridin-4(1H)-ones.
    Romero AH; López SE; Rodríguez N; Oviedo H
    Arch Pharm (Weinheim); 2018 Jun; ():e1800094. PubMed ID: 29926967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Rosales MJ; Campayo L; Cano C; Sanz AM; Yunta MJ
    Parasitology; 2015 Jul; 142(8):1115-29. PubMed ID: 25823476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of new terpenoid derivatives against Leishmania infantum and Leishmania braziliensis.
    Ramírez-Macías I; Marín C; Chahboun R; Olmo F; Messouri I; Huertas O; Rosales MJ; Gutierrez-Sánchez R; Alvarez-Manzaneda E; Sánchez-Moreno M
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):370-6. PubMed ID: 22510833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
    Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
    Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.
    Abdala H; Alvarez N; Delmas F; Di Giorgio C; Robert JM; Le Baut G; Le Pape P
    Parasite; 2002 Dec; 9(4):367-70. PubMed ID: 12514953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.